也许,这真是医疗上一个关键时刻的到来。中美医学界正携起手来,面对人类共同的健康死敌联合作战。对于美国细胞技术公司总裁泰伦斯·什莱来说,没有什么比这更有意义了。他从大洋彼岸飞来,圆满地完成了一个使命:与中国医学科学院拟定一项长期开办合资企业的协约。按照这个协约,该公司将为中国的癌症患者提供该公司所生产的生物免疫药品,同 Perhaps, this is really a medical critical moment of arrival. The medical community in both China and the United States are joining forces to face the common health and rival unity of mankind in joint operations. Nothing makes more sense than that for Terrence Shylley, president of American Cell Technologies. He flew across the ocean and successfully completed his mission of drafting an agreement with the Chinese Academy of Medical Sciences for a long time to start a joint venture. According to the agreement, the company will provide China’s cancer patients with the company’s bio-immune drugs,